drug3 weeks ago
BioAegis Leverages Gelsolin’s Broad Therapeutic
NORTH BRUNSWICK, N.J., Jan. 06, 2023 (GLOBE NEWSWIRE) — BioAegis Therapeutics, Inc., a clinical-stage firm creating therapies for inflammatory illnesses by a portfolio constructed round plasma...
